Sennosides,Docusate sodium is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Ncs Healthcare Of Ky, Inc Dba Vangard Labs. The primary component is Docusate Sodium; Sennosides.
| Product ID | 0615-8276_18c8eeff-7363-471b-834a-85ff04d211b4 |
| NDC | 0615-8276 |
| Product Type | Human Otc Drug |
| Proprietary Name | Sennosides,Docusate sodium |
| Generic Name | Sennosides,docusate Sodium |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-12-20 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
| Substance Name | DOCUSATE SODIUM; SENNOSIDES |
| Active Ingredient Strength | 50 mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-02-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2019-02-22 |
| Ingredient | Strength |
|---|---|
| DOCUSATE SODIUM | 50 mg/1 |
| SPL SET ID: | 17d590a7-6698-497f-a35e-50c51d432726 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0536-1169 | Sennosides,Docusate sodium | Sennosides,Docusate sodium |
| 0615-8276 | Sennosides,Docusate sodium | Sennosides,Docusate sodium |
| 0904-6724 | Sennosides,Docusate sodium | Sennosides,Docusate sodium |
| 55154-7299 | Sennosides,Docusate sodium | Sennosides,Docusate sodium |
| 70518-1885 | Sennosides,Docusate sodium | Sennosides,Docusate sodium |